9.16 USD
↘ 0.34 (3.58%)AT CLOSE (11:59 AM EDT)
Ocular Therapeutix, Inc.
OCULNASDAQ • USD
9.19
↗ 0.03 (0.32%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
9.19
↗ 0.03 (0.32%)
Market: CLOSED
Open?$9.29
High?$9.36
Low?$9.04
Prev. Close?$9.50
Volume?2.4M
Avg. Volume?3.1M
VWAP?$9.17
Rel. Volume?0.77x
Bid / Ask
Bid?$9.08 × 200
Ask?$9.25 × 2.0K
Spread?$0.17
Midpoint?$9.17
Valuation & Ratios
Market Cap?2.0B
Shares Out?219.0M
Float?179.1M
Float %?82.3%
P/E Ratio?N/A
P/B Ratio?3.45
EPS?-$1.33
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Themes
Address
14 CROSBY DRIVE, 3RD FLOOR
BEDFORD, MA 01730
Phone: 781-357-4000
BEDFORD, MA 01730
Phone: 781-357-4000
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?14.81Strong
Quick Ratio?14.73Strong
Cash Ratio?13.98Strong
Debt/Equity?0.12Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?3.45FAIR▾
P/S?38.54HIGH▾
P/FCF?N/A▾
EV/EBITDA?-4.8CHEAP▾
EV/Sales?27.12HIGH▾
Returns & Efficiency
ROE?-50.0%WEAK▾
ROA?-39.7%WEAK▾
Cash Flow & Enterprise
FCF?$-240944000
Enterprise Value?$1.4B
Fundamentals ratios updated end of day